Trial Details

COMPLETED
Basic Information
Clinical ID c1044
Identifier NCT01408810
Trial Title Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: Infliximab
Participant Information
Sponsor Grupo de Estudo da Doença Inflamatória Intestinal
City Porto
Country/Region Portugal
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2025-02-11
Primary Completion Date 2025-11-12
Completion Date 2025-11-12